High treatment modification rates with lamivudine therapy in HBV-infected patients with low baseline viremia and early virological response: A multicenter study


Gonen C., Gunduz F. , Doganay L., Enc F. Y. , Yegin E. G. , Ahishali E., et al.

JOURNAL OF DIGESTIVE DISEASES, cilt.16, ss.286-292, 2015 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 16 Konu: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/1751-2980.12237
  • Dergi Adı: JOURNAL OF DIGESTIVE DISEASES
  • Sayfa Sayısı: ss.286-292

Özet

ObjectiveLow baseline viremia and an early treatment response predict the best outcomes in hepatitis B virus (HBV)-infected patients treated with nucleoside analogues with low barriers to resistance. The aim of this study was to assess the long-term results and effectiveness of lamivudine in patients with low baseline viremia and early virological treatment response.